IndraLab

Statements

RIPK1 binds TRAF2 and CYLD. 2 / 2

| 2

sparser

"TNFα treatment increases the binding between PrP and the deubiquitinase tumor suppressor cylindromatosis (CYLD), in these treated cells, binding of CYLD to RIP1 and TRAF2 is reduced."

28900035

➶

sparser

"Interactions between CYLD and RIP1 or TRAF2 were specific as isotype controls did not pull down any CYLD ( xref , A and B )."

28900035

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

RIPK1 binds TRAF2 and CYLD. 2 / 2

INDRA sources:

Databases

Reading